Posted by: university professor of Pharmaceutical and medicinal chemistry

03/25/2008

I want to congratulate with the authors of the article. We know in general what the pharmaceutical industries really search for: money. But each day we learn that they are capable or worse things do get what they want. Shame on these industries! This situation reminds me a Dylan' s phrase: when you think you have lost everything you find out you can loose a litle more...
I still believe we can make things work better for everybody but is really hard to work against such power. Each day we loose a litle more...

Posted by: Chief Executive, Phyto Specialities Pvt. Ltd.

03/03/2008

It is clear that almost all the Pharma companies have become just a commercial organisation and nothing more. The focus in only on profits and not on social contribution nor how they earn their profits. So every company that hits a new molecule in their research whether it contributes any real benifit or not, it goes in for IP rights and just commercial exploitation.

As long as we look every activity as profit making activity and as long as we measure every outcome only in terms of commerce this is where we will end up.

There is a need for paradigm shift in the way we look at research in Health care and its outcome and the way we make our profits.

Unless an outcome of our R&D offers a real and better solution to an existing health care problem it should not qualify for commercial exploitation.

Reasearch should be directed not with an objective of making profit but to find a real and better solution to the health care problems.

Posted by: Product Specialist

02/27/2008

As for as the Biotech innovation is concern it is confidential & companies priorties depends when to disclose it for benefits.Oversizing with less effective molecules with less significance in health management creating a new sort of buying/seeling concept in patients/doctors mind. Well relatively creating temperory hype in the field followed by meltdown of this Pharmaceutical market.Problem is not the Big R & D investment or promation budget it is focus of top brass CEOs to unethical profit gain.

Posted by: Prof. of Chemistry, Purdue University

02/15/2008

The last issue of GEN included a Point of View piece by Dr. Henry Miller suggesting the only purpose of a corporation is to reward shareholders. I disagree, but if Miller is right, then what pharma do to maximize shareholder value is perfectly logical and expected. I believe pharma companies have done themselves much damage by acting like consumer products companies. This was not anticipated, but sinking from the most admired industry in America in the mid-90s to one with a reputation near that of the US Congress today has resulted from this change. Let's just say it is very complicated and the industry is in another huge transition. But into what?
We can't know at this point.